Summary The streptococcal preparation OK432 was studied for its effects on natural killer (NK) activity of peripheral blood lymphocytes (PBL) from normal donors and from ovarian cancer patients, and of tumourassociated lymphocytes (TAL) from peritoneal effusions. OK432 augmented NK activity against the susceptible K562 line and induced killing of the relatively resistant Raji line. Freshly isolated ovarian carcinoma cells were relatively resistant to killing by unstimulated PBL and TAL. OK432 induced significant, though low, levels of cytotoxicity against 5'Cr-labelled ovarian carcinoma cells. Augmentation of killing of fresh tumour cells by OK432 was best observed in a 20h assay and both autologous and allogeneic targets were lysed. PBL were separated on discontinuous Percoll gradients. Unstimulated and OK432-boosted activity were enriched in the lower density fractions where large granular lymphocytes (LGL) and activity against K562 were found. Thus, OK432 augments NK activity of PBL and TAL in human ovarian carcinomas and induces low, but significant, levels of killing of fresh tumour cells. Effector cells involved in killing of fresh ovarian tumours copurify with LGL on discontinuous gradients of Percoll.
Natural killer (NK) cells are defined on the basis of their ability to cause rapid lysis of susceptible target cell lines in the absence of overt sensitization (Cudkowicz et al., 1978; Herberman & Holden, 1978; Herberman, 1982) . A role for NK cells has been suggested in surveillance against neoplasia and in the regulation of growth of established tumours and metastasis (Cudkowicz et al., 1978; Cudkowicz & Hockman, 1979; . The regulation of NK activity is complex and various agents have been shown to stimulate natural cytotoxicity (Cudkowicz et al., 1978; Cudkowicz & Hockman, 1979; Herberman & Holden, 1978; Herberman, 1982) . OK432 is a streptococcal preparation with immunomodulatory activity (Uchida & Hoshino, 1980a, b) . OK432 has been shown to augment NK activity in vivo or in vitro, in rodents and humans (Oshimi et al., 1980; Uchida & Micksche, 1981,a, b) . IFN and interleukin 2 (IL2) may be involved in the activation of NK cells by OK432 (Wakasugi et al., 1982) . Unlike cell lines, fresh tumour cells are usually relatively resistant to natural cytotoxicity by unstimulated effector cells (Moore et al., 1982; Pattengale et al., 1982; Serrate et al., 1982; Vanky et al., 1980; Verkmeister et al., 1979; Vose et al., 1977a, b; Vose & Moore, 1980; Zarling et al., 1979) . Vanky et al., (1980) showed that in various Correspondence: F. Colotta. Received 21 April 1983; accepted 8 July 1983. human tumours IFN could induce or augment cytotoxicity against fresh neoplastic cells provided allogeneic combinations of effectors and targets were studied. As found for other human tumours, freshly isolated ovarian carcinoma cells were relatively resistant to NK activity Mantovani et al., 1980) . In vitro exposure of effector cells (both allogeneic and autologous) to IFN caused modest enhancement of lysis using lymphoid cells isolated from peripheral blood and ascites tumour Mantovani et al., 1980) . The capacity of OK432 to stimulate NK activity prompted us to investigate the effect of this agent on natural cytotoxicity in human ovarian carcinoma, a tumour previously studied for this parameter in some detail Introna et al., 1983; Mantovani et al., 1980; Target cells NK activity of PBL was measured against the highly sensitive K562 (Allavena et al., 1981) and relatively resistant Raji cell lines (Pulvertaft, 1965) . Target cells were pre-incubated with 20-50 pCi 51Cr (Radiochemical Centre, Amersham, Buckinghamshire, England) at 37°C fpr 45 min.
Fresh ovarian carcinoma cells (1-5 x 106 in 0.2-1ml growth medium) were labelled by incubation for 20h at 37°C (overnight) with 20-50pCi 51Cr (Kedar et al., 1981) .
Labelled cells were washed twice with 50ml of PBS before use in cytolysis assays.
Cytotoxicity assay 51Cr labelled tumour cells (104) were cultured in 0.1 ml RPMI 1640 medium with 10% serum in round-bottomed wells of Microtest plates (Sterilin Ltd., Teddington, Middlesex, England). The routinely employed attacker:target (A:T) ratios were 25:1 and 50:1 for ovarian carcinoma cells. Lysis of K562 and Raji was routinely measured at A:T ranging from 6:1 to 50:1, but only data for 25:1 (K562) and 50:1 (Raji) are presented. Isotope release was determined after 4 and 20 h of incubation, except for occasional experiments in which cytotoxicity was measured only at 4 h. (Introna et al., 1983; Timonen & Saksela, 1980; Timonen et al., 1981) . Briefly, discontinuous gradients of Percoll (7 steps) from 42.5% to 55% (v/v) were prepared with RPMI 1640 medium with 10% FBS, after adjusting the osmolarity to 285mosmol. Cells were deprived of monocytes by adherence on plastic, carbonyl iron and nylon wool columns and kept at 4°C overnight before fractionation at 550g for 30min.
Enrichment in large granular lymphocytes (LGL) was evaluated on May-Grunwald-Giemsa stained cytocentrifuge smears (Introna et al., 1983; Timonen & Saksela, 1980; Timonen et al., 1981 
Results
A first series of experiments was designed to define the conditions for optimal augmentation of normal PBL NK activity against cell lines (K562 and Raji) by OK432. Fibroblast IFN was used as a standard immunostimulatory agent. In agreement with previous reports OK432 augmented lysis of the NK susceptible K562 target (Figure 1 ) and induced killing of the relatively resistant Raji line (Figure 2 ). Optimal stimulation was observed at OK432 concentrations of 0.1-0.5KEml-1 and after incubation times of 20 h (data not shown). Therefore in subsequent experiments effector cells were exposed to 0.5KEml-' for 20h. Previous studies have shown that TAL from ascites and, to an even greater extent, solid ovarian tumours have (Allavena et al., 1981) usually low NK activity compared to PBL effectors . It was therefore of interest to elucidate whether OK432 stimulated NK activity (vs. K562) of TAL and, by way of comparison, of PBL from ovarian cancer patients. As shown by the representative experiment in Table II , OK432 was effective at stimulating NK activity of PBL and TAL and, Table III, while Table IV  presents all experiments performed and Table V sets out a synopsis of overall effect of OK432 on killing of fresh ovarian carcinoma cells. OK432 was able to augment cytotoxicity against fresh ovarian tumours with all effector populations tested (normal PBL, ovarian cancer PBL and TAL). OK432-induced cytotoxicity was best observed when a 20 h assay was performed. Boosting of cytotoxicity was rarely observed, particularly with PBL and TAL from ovarian cancer patients in a 4 h assay (only in 2/8 cases with PBL and 1/9 with TAL) with low levels of stimulation (absolute increases in lysis, 11.0% and 9.6% for PBL and 7.2% for TAL). Augmentation of killing of fresh ovarian tumours was best evident in a 20h 5"Cr release assay, both in terms of the frequency of positive responses (for instance for TAL 5/7 at 20h compared to 1/9 at 4 h) and in terms of absolute levels of specific lysis attained (Table IV) . OK432 augmented the cytotoxic activity of PBL and TAL against both autologous and allogeneic target cells. For instance in the experiments shown in Table III (Tables III and IV) , OK432 resulted in significantly higher cytotoxicity levels than did IFN. Moreover, OK432 treatment resulted in a significantly higher frequency of stimulation than IFN (Table V) . For instance, using TAL as effectors, OK432 resulted in significant stimulation of lysis in 5/7 autologous combinations tested whereas this occurred in only 1/5 experiments with IFN (P<0.05). Effector cells involved in NK activity against cell lines (K562) have been identified as LGL (Saksela et al., 1979; Timonen et al., 1979a, b) . It was of interest to determine whether effector cells involved in killing of fresh ovarian carcinoma cells were indeed LGL. Blood LGL sedimented in low density Percoll fractions with an enrichment of 4-7 times compared with unfractioned PBL: in the experiment presented in Table VI the % LGL in fraction 2 was 70.3% compared to 11.3% of the input population and 0.6% of fraction 7. The distribution of NK activity against K562 closely followed that of LGL ( Figure  4) . Interestingly, basal and OK432-boosted (x 10-6) cells (%)
LGL ( Fractions of density gradient activities against fresh ovarian carcinoma no. 8 closely followed the sedimentation profile of LGL and anti K562 activity (Figure 4 ).
Discussion
Previous reports have shown that the streptococcal preparation OK432 is an effective stimulator of NK activity in human (Uchida & Micksche, 1981a,b) . The mechanism of action is, however, a matter of controversy. It has been suggested that induction of IFN is not involved in augmentation of NK activity by this agent (Uchida & Micksche, 1982 Although suppressor mechanisms can be demonstrated in the ascites of some ovarian cancer patients (Allavena et al., 1981; Introna et al., 1982) evidence has suggested that defective NK activity of TAL was mainly related to a low frequency of LGL (Introna et al., 1983; Introna & Mantovani, 1983) unlike pleural effusions where high numbers of LGL were reported (Uchida & Micksche, 1981a) . Hence it appears unlikely that interference with suppressor mechanisms plays a major role in boosting of NK activity of TAL from ascites ovarian tumours.
Fresh tumour cells from human neoplastic tissues are generally resistant to natural cytotoxicity as measured by conventional cytolysis assays (Pattengale et al., 1982; Serrate et al., 1982; Vanky et al., 1980; Verkmeister et al., 1979; Vose et al., 1977a Vose et al., , 1977b Vose et al., , 1978 Vose & Moore, 1980; Zarling et al., 1979) . In a study with various human tumours, mainly of mesenchymal origin, Vanky et al. reported that IFN-induced killing of fresh biopsy cells only if allogeneic combinations of PBL and target cells were used (Vanky et al., 1980) . Killing of fresh leukaemic targets by normal allogeneic effectors was reported by Moore et al. (1982) . Results with ovarian tumours were to some extent different. In the absence of stimulation PBL and TAL from ovarian cancer patients showed no evidence of appreciable cytotoxicity against autologous targets Figure  3 ), whereas -30% of subjects with other human tumours have PBL cytotoxic against autologous neoplastic cells (Vose et al., 1977a (Vose et al., , 1978 Zarling et al., 1979) . However when lung cancer was considered by histological subtype, evidence for autologous recognition was confined to squamous cell carcinoma and to adenocarcinoma (Vose et al., 1978) . Our previous findings with ovarian carcinoma were confirmed in the limited series of subjects considered in the present study. In vitro exposure to OK432 and, to a lesser extent, IFN induced significant levels of lysis of ovarian carcinoma cells, thus extending previous observations with IFN . Stimulation of lysis by OK432 was best observed in a 20h assay with normal PBL, ovarian cancer PBL and TAL. Why OK432 induced lysis of fresh tumour cells was best observed in a 20 h assay remains to be clarified. A possible explanation for this finding is that OK432 augments the maximal recycling capacity of effector cells, a possibility which is currently being tested. When ovarian cancer PBL and TAL are considered, OK432 augmented lysis against both autologous and allogenic fresh carcinoma cells, thus extending previous findings with IFN . Uchida & Micksche (submitted for publication) recently made similar observations with lung carcinoma cells as targets and these authors as well as Serrate et al. (1982) found that low density fractions from Percoll gradients had activity against autologous and allogeneic tumour biopsy cells.
The effector cells involved in OK432-induced killing of fresh ovarian carcinoma cells were not definitively identified in the present study. Monocyte cytotoxicity is not affected by OK432 (Rossi et al., unpublished data) , and stimulation of natural cytotoxicity was observed with cell preparations depleted of monocytes by adherence on plastic followed by passage through nylon wool. Upon fractionation on discontinuous Percoll gradients both basal and OK432-stimulated killing of fresh ovarian carcinomas were augmented in the low density fractions, where LGL and anti-K562 activity were recovered. These results tentatively suggest that LGL may be involved in cytotoxicity against fresh ovarian carcinoma cells, but the effector cells involved in this reactivity require more definitive characterization.
